Skip to main content
Caplight Logo









Kinnos

Kinnos

Private
Brooklyn, New YorkHealthcare & Life Scienceshttps://www.kinnos.com/

Last Round

Early Funding

May 2, 2023

Total Funding Raised

$22M

Momentum

Top 5%

of companies Caplight tracks

Company Overview

Kinnos is a healthcare technology company that develops and manufactures Highlight®, a patented color additive platform for disinfectants designed to improve cleaning compliance and surface coverage.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Facility Management, Quality Management

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

infection preventiondisinfection enhancementsurface disinfectioninfection controlhospital hygienecleaning complianceEVSenvironmental serviceshospital cleaningrazor and blades modelcolor-additive technologydisinfectant wipesvisual cleaning verificationhealthcare facility managementmedical device

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Kinnos Comparables

Compare Kinnos with similar companies based on industry and business-model similarity.

Kinnos comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Ecolab
71%
Optisolve
70%
Professional Disposables International, Inc.
66%

Kinnos Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Early FundingMay 2, 2023
Series AMar 5, 2020
SeedFeb 27, 2017

Key People

Founding team and executive leadership

Jason Kang

Co-Founder and CEO

Founding Team

Kinnos Investors

Notable investors and investment history

Kinnos investors
InvestorRounds
Partnership for New York CityEarly Funding
MEDA AngelsSeries A
Prolog VenturesSeries A
New York AngelsSeed
The New York City Investment FundEarly Funding
Kapor CenterEarly Funding
Golden SeedsSeries A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 22, 2026

    Monthly visitors grew 55% MoM.

  • Apr 1, 2025

    Product 'Highlight' recognized in Fierce Life Sciences’ Innovation Awards.

Kinnos Filings

Explore SEC and related filing metadata, where available.

Kinnos filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Kinnos's valuation, stock price, and market status.

Is Kinnos a public or private company?

Kinnos is a private company.

What is the current stock price of Kinnos?

Kinnos is a private company with no public stock price. No recent secondary market data is available.

How much is Kinnos worth (valuation)?

Valuation information for Kinnos is not publicly available.

Can I buy Kinnos stock?

Kinnos shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Kinnos's last funding round?

Kinnos's most recent funding round was Early Funding on May 2, 2023.

Who are the main investors in Kinnos?

Key investors in Kinnos include Partnership for New York City, The New York City Investment Fund, Kapor Center.

Will Kinnos IPO soon?

No public IPO plans have been announced for Kinnos.

How can I track Kinnos secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Kinnos's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersBrooklyn, New York
Employee Range7
Year Founded2014
Last FundingMay 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?